Cara Therapeutics (NASDAQ: CARA) ranks as one of the hottest biotech stocks on the market. Shares have soared more than 60% so far in 2019 as investors eagerly anticipate results from a late-stage study that could lead to Cara winning approval for its first product.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,